Antihypertensive Prescribing Practices: Impact of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial

Journal of Clinical Hypertension

Volumn 8, Issue 12, 2006, Pages 860-864

  Player, Marty S ^a   Gill, James M ^b   Fagan, Heather Bittner ^c   Mainous, Arch G ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c CHRISTIANA CARE HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIHYPERTENSIVE AGENT; ANTILIPEMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXAZOSIN; PRAZOSIN; TERAZOSIN; THIAZIDE DIURETIC AGENT;

ADULT; ARTICLE; CLINICAL PRACTICE; CROSS-SECTIONAL STUDY; DATA ANALYSIS; ELECTRONIC MEDICAL RECORD; FEMALE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; MIDDLE AGED; MULTICENTER STUDY (TOPIC); PHYSICIAN ATTITUDE; PRESCRIPTION; PRIORITY JOURNAL; PROTOCOL COMPLIANCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME; DRUG USE; FACTUAL DATABASE; HYPERLIPIDEMIA; MEDICAL RECORD; STATISTICS; UNITED STATES;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ANTILIPEMIC AGENTS; CALCIUM CHANNEL BLOCKERS; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DRUG UTILIZATION REVIEW; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MEDICAL RECORDS; MIDDLE AGED; MYOCARDIAL INFARCTION; PHYSICIAN'S PRACTICE PATTERNS; SODIUM CHLORIDE SYMPORTER INHIBITORS; UNITED STATES;

EID: 39049182290     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/j.1524-6175.2006.05781.x     Document Type: Article

References (25)

1. Cherry DK, Woodwell DA. National Ambulatory Medical Care Survey: 2000 summary. Adv Data. 2002;328:1–32.
2. Lewington S, Clark R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360:1903–1913.
3. Cutler JA, MacMahon SW, Furberg CD. Controlled clinical trials of drug treatment for hypertension. A review. Hypertension. 1989;13:I-36–I-44.
4. Chalmers J, Zanchetti A. The 1996 report of a World Health Organization expert committee on hypertension control. J Hypertens. 1996;14:929–933.
5. Collins R, Peto R, Godwin J, et al. Blood pressure and coronary heart disease. Lancet. 1990;336:370–371.
6. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis. JAMA. 1997;277:739–745.
7. Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomized trials. Blood Pressure Lowering Treatment Trialists' Collaboration. Lancet. 2000;356:1955–1964.
8. Psaty BM, Lumley T, Furberg CD, et al. Health out-comes associated with various antihypertensive therapies used as first-line agents: a network meta-analysis. JAMA. 2003;289:2534–2544.
9. Rosei EA, Dal Palu C, Leonetti G, et al. Clinical results of the Verapamil in Hypertension and Atherosclerosis Study. J Hypertens. 1997;15:1337–1344.
10. UK Prospective Diabetes Study Group. Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39. BMJ. 1998;317:713–720.
11. Hansson L, Lindholm LH, Ekbom T, et al. Randomized trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity: the Swedish Trial in Old Patients with Hypertension-2 (STOP-2) study. Lancet. 1999;354:1751–1756.
12. Brown MJ, Palmer CR, Castaigne A, et al. Morbidity and mortality in patients randomized to double-blind treatment with a long-acting calcium channel blocker or diuretic in the International Nifedipine GITS Study: Intervention as a Goal in Hypertension Treatment (INSIGHT). Lancet. 2000;356:366–372.
13. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002;288:2981–2997.
14. Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. The fifth report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood pressure. Arch Intern Med. 1993;153:149–152.
15. Siegel D. The influence of national guidelines on antihypertensive prescribing practices. Curr Hypertens Rep. 2000;2:247–252.
16. Hyman DJ, Pavlik VN. Self-reported hypertension treatment practices among primary care physicians: blood pressure thresholds, drug choices, and the role of guidelines and evidence-based medicine. Arch Intern Med. 2000;160:2281–2286.
17. Knight EL, Glynn RJ, Levin R, et al. Failure of evidence-based medicine in the treatment of hypertension in older patients. J Gen Intern Med. 2000;15:702–709.
18. Moser M. Why are physicians not prescribing diuretics more frequently in the management of hypertension? JAMA. 1998;279:1813–1816.
19. Siegel D, Lopez J. Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? JAMA. 1997;278:1745–1748.
20. Xie F, Petitti D, Chen W. Prescribing patterns for antihypertensive drugs after the Antihypertensive and Lipid-Lower Treatment to Prevent Heart Attack Trial: report of experience in a health maintenance organization. Am J Hypertens. 2005;18:464–469.
21. Stafford RS, Furberg CD, Finkelstein SN, et al. Impact of clinical trial results on trends in alpha-blocker prescribing, 1996–2000. JAMA. 2004;291:54–62.
22. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560–2571.
23. Hueston WJ, Mainous AG 3rd, Ornstein S, et al. Antibiotics for upper respiratory tract infections. Follow-up utilization and antibiotic use. Arch Fam Med. 1999;8:426–430.
24. Gill JM, Foy AJ, Ling Y. Quality of outpatient care for diabetes mellitus in a national electronic health record network. Am J Med Qual. 2006;21:13–16.
25. Gill JM, Fleischut P, Haas S, et al. Use of antibiotics for adult upper respiratory infections in outpatient settings: a national ambulatory network study. Fam Med. 2006;38:349–354.